The FDA has approved Secuado (asenapine; Noven) transdermal system for the treatment of adults with schizophrenia. The Food and Drug Administration has approved Secuado (asenapine; Noven) transdermal ...

The US Food and Drug Administration (FDA) has approved donepezil transdermal system (Adlarity) for patients with mild, moderate, or severe Alzheimer's disease (AD), the manufacturer has announced.

Neuland enters development collaboration with LIR Life Sciences for transdermal GLP-1: Our Bureau, Bengaluru Thursday, May 7, 2026, 13:30 Hrs [IST] Neuland Laboratories, a global ...

BUTRANS (buprenorphine) 5mcg/hr, 10mcg/hr, 20mcg/hr transdermal patch by Purdue The FDA has approved Purdue's Butrans (buprenorphine) Transdermal System for the management of moderate to severe ...

Purpose: The efficacy and safety of fentanyl hydrochloride patient-controlled trans-dermal system (PCTS) for management of acute postoperative pain are discussed. Summary: Fentanyl hydrochloride PCTS ...

The size of protein-based drug molecules prevents their absorption into the body when taken orally making injection (intramuscularly, subcutaneously, intravenously, etc.) the only effective delivery ...

Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function More than 800 million people have Chronic ...

Transdermal drug delivery is valued by patients and physicians for the comfort and convenience it offers — no needles, no pills and ease of use Transdermal drug delivery is valued by patients and ...

PARSIPPANY, N.J., Oct. 21, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that the U.S. Food and Drug Administration (FDA) approved its Androderm® (testosterone ...

LOD, Israel--(BUSINESS WIRE)-- TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal ...

Pune, March 04, 2025 (GLOBE NEWSWIRE) -- “According to SNS Insider, the global Transdermal Drug Delivery System Market was valued at USD 7.23 billion in 2023, is projected to reach USD 10.77 billion ...